Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2016	Sep. 25, 2015
Current assets:
Cash and cash equivalents	$ 516,112	$ 531,926
Restricted cash	3,645	2,936
Short-term investments	121,629	138,901
Accounts receivable, net of allowance for doubtful accounts of $2,370 and $1,542	75,688	101,563
Inventories	16,354	13,872
Prepaid expenses and other current assets	26,302	32,031
Total current assets	759,730	821,229
Long-term investments	393,904	321,015
Property, plant and equipment, net	443,656	403,091
Intangible assets, net	215,342	127,507
Goodwill	309,616	307,708
Deferred taxes	166,790	143,279
Other non-current assets	21,068	9,464
Total assets	2,310,106	2,133,293
Current liabilities:
Accounts payable	17,544	20,710
Accrued liabilities	169,055	169,307
Income taxes payable	2,304	754
Deferred revenue	24,180	18,910
Total current liabilities	213,083	209,681
Long-term deferred revenue	35,366	30,581
Other non-current liabilities	82,922	77,024
Total liabilities	331,371	317,286
Stockholders' equity:
Additional paid-in capital	42,032	17,571
Retained earnings	1,938,320	1,800,857
Accumulated other comprehensive income	(10,197)	(11,462)
Total stockholders’ equity – Dolby Laboratories, Inc.	1,970,256	1,807,068
Controlling interest	8,479	8,939
Total stockholders’ equity	1,978,735	1,816,007
Total liabilities and stockholders’ equity	2,310,106	2,133,293
Class A Common Stock [Member]
Stockholders' equity:
Common stock	57	51
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 44	$ 51